ArticleNAR genomics and bioinformatics2026
From gene correlations to cell clusters: COTAN improved scRNA-seq analysis.
Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA-sequencing (scRNA-seq) now routinely profiles thousands of individual transcriptomes, yet no consensus pipeline exists for either laboratory protocol or downstream analysis. Droplet-based datasets are especially challenging: their count matrices are extremely sparse and many biologically important genes are expressed at very low levels. Standard workflows, borrowed from bulk RNA-seq, apply normalization, log-transformation, and feature filtering, steps that can distort true-zero counts and systematically discard low-expression regulators. A method that natively handles sparsity, avoids imputation, and retains informative low-abundance genes is therefore desirable. We present an extended version of the COTAN workflow, a framework based on gene correlations that models zero counts directly, requires no log-normalization or scaling, and is tailored to UMI droplet data. COTAN's key features are (i) robust gene-gene correlation matrices, validated on diverse public datasets, (ii) a superior detection of differentially expressed genes, including those with very low expression, consistently outperforming leading tools, (iii) a highly sensitive statistical scoring, able to detect heterogeneous cell groups and to confirm whether a cluster is truly transcriptomically uniform. Together, these advances provide a biologically grounded, end-to-end solution for scRNA-seq analysis. COTAN is available in Bioconductor and on GitHub. Supplementary information is available at this site.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.